• Agenda
  
• Brochure
• CE Credit
  
• Course Directors & Faculty
• Registration

Target Audience
General practitioners, surgeons, ENTs, nurses, nurse practitioners, radiologists, health techs, oncologists, radiation oncologists, physical therapists, rehabilitation specialists, physiatrists and neurologists.

Agenda
Saturday, May 20, 2023
8:00 am
Registration & Breakfast

8:20 am
Welcome by Drs. Mistry & Williams

8:30 am – 9:20 am
UofL Health and Brown Cancer Center Neuro-Oncology Immunotherapy Clinical Trials
Dr. Brian Williams

9:20 am – 9:25 am
Q&A

9:25 am – 10:15 am
GlioDex: A Randomized Clinical Trial Proposal
Dr. Akshitkumar Mistry

10:15 am –10:20 am
Q&A

10:20 am – 10:30 am
Break

10:30 am – 11:20 am
Rehab for Neuro-oncology
Dr. Megan Nelson

11:20 am – 11:25 am
Q&A

11:25 am – 12:15pm
KEYNOTE: The Evolution of Immunotherapy: Lessons Learned From Melanoma
Dr. Michael Egger

12:15 pm – 12:20 pm
Q&A

12:20 pm – 1:00 pm
Lunch

1:00 pm – 1:50 pm
Leveraging Zika Virus and the Immune System to Treat GBM
Dr. Sharmila Nair

1:50 pm – 1:55 pm
Q&A

2:00 pm
Adjourn

Course Directors
Akshitkumar Mistry, MD
Assistant Professor
Specialty: Brain Tumor Program
Department of Neurosurgery
University of Louisville
Louisville, Kentucky

Brian Williams, MD
Director of Brain Tumor Program
Neurosurgery Residency Program Co-Director
Assistant Professor Neurosurgery
Department of Neurological Surgery
University of Louisville School of Medicine

Participating Faculty
Michael Egger, MD, MPH    
Assistant Professor
Department of Surgery
University of Louisville
Louisville, Kentucky

Sharmila Nair, PhD    
Assistant Professor
Department of Microbiology and Immunology
University of Louisville
Louisville, Kentucky

Megan Nelson, MD
Associate Professor
Specialty: Cancer Rehabilitation
Department of Neurosurgery
Division of Physical Medicine & Rehabilitation
University of Louisville
Louisville, Kentucky

Learning Objectives
As a result of participating in this activity, participants should be able to:

1. Discuss the biology and progress of immunotherapy in oncology and the application to neuro-oncology.
2. Describe the treatment options currently in use both locally and nationally in the treatment of brain tumors.
3. Identify was to update current care practices with neuro-oncology patients through surgery, rehab, clinical trials, and research.
4. Identify and discuss trends and future treatment options for brain tumors currently being researched with immunotherapy.

Continuing Education Credit
Physician Credit - The University of Louisville Continuing Medical Education office designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse - This program has been approved by the Kentucky Board of Nursing for 5.5 continuing education credits through University of Louisville Hospital, provider number 4-0068-12-24-1333. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content. Completion criteria to obtain CE's: Attend entire session and complete the evaluation.

Accreditation Statement
The University of Louisville School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Special Services
All individuals are encouraged to participate. To request disability arrangements, please contact the Ricardo Rivera at least 7 days prior to the date of this program. Continuing Medical Education and Professional Development fully complies with the legal requirements of the ADA and the rules and regulations thereof.

Brochure
CLICK HERE for a copy of the course Flyer (Available Soon)

Registration
Registration Fees:There is no fee to attend this event. Advance registration is required to allow for event planning.

In-person Conference
CLICK HERE to Register for the Live In-person Conference   

Live Webinar
CLICK HERE to Register for the Webinar version of this Conference
An email will be sent to all registrants 1 week prior and again 2 days prior with instructions for webinar sign-in.

Acknowledgments
We thank our supporting and exhibiting companies for their participation in the "Neuro-Oncology Symposium 2023: Immunotherapy in Neuro-oncology" conference. A final listing of supporters and exhibitors will be available at the meeting.

Accreditation Disclosure
As a provider accredited by the ACCME, the Office of CME&PD, School of Medicine, University of Louisville, must ensure balance, independence, objectivity, and scientific rigor in all its accredited educational activities. All Planners, faculty, reviewers, and other persons that affected the content of this CME activity were required to submit a financial disclosure form from which relevant conflicts of interest were determined. If any relevant financial relationship(s) with ineligible companies were disclosed, the materials each of them prepared for this program (or influenced) were peer-reviewed and determined to be without ineligible company bias, were considered fair and balanced in terms of therapeutic options, and presented evidence-based content. All relevant financial relationships with ineligible organizations have been mitigated prior to this activity.

Learner Consent Statement
Names or contact information of learners will not be shared with any ineligible company or its agents without the explicit consent of the individual learner.